Key Insights

Highlights

Success Rate

69% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 42/100

Termination Rate

22.2%

4 terminated out of 18 trials

Success Rate

69.2%

-17.3% vs benchmark

Late-Stage Pipeline

72%

13 trials in Phase 3/4

Results Transparency

78%

7 of 9 completed with results

Key Signals

7 with results69% success

Data Visualizations

Phase Distribution

17Total
P 1 (1)
P 2 (3)
P 3 (9)
P 4 (4)

Trial Status

Completed9
Terminated4
Withdrawn2
Recruiting1
Unknown1
Active Not Recruiting1

Trial Success Rate

69.2%

Benchmark: 86.5%

Based on 9 completed trials

Clinical Trials (18)

Showing 18 of 18 trials
NCT06431373Phase 3Active Not Recruiting

A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis

NCT05486468Phase 3Recruiting

The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterior Segment

NCT05101928Phase 4Withdrawn

Ozurdex Monotherapy Trial

NCT05070728Phase 3Terminated

Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal (FAI) Insert

NCT05953688Phase 2Terminated

POC Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Active Intermediate, Posterior, or Pan NIU

NCT06085079Phase 4Unknown

Ixekizumab for the Management of Refractory Non-Infectious Uveitis: A Proof-of-Concept Study

NCT03656692Phase 4Terminated

Safety and Effectiveness of Acthar Gel for Inflammation of the Eye's Uvea (Middle Layer)

NCT03097315Phase 3Completed

Suprachoroidal Injection of CLS-TA in Patients With Non-infectious Uveitis

NCT02952001Completed

MAGNOLIA: Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301

NCT02595398Phase 3Completed

Suprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious Uveitis

NCT02255032Phase 2Completed

Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious Uveitis

NCT02049476Phase 4CompletedPrimary

Study of the Effectiveness of Ozurdex for the Control of Uveitis

NCT01905124Phase 2Withdrawn

Safety &Efficacy of CF101 to Subjects With Uveitis

NCT01092533Phase 3CompletedPrimary

Myfortic for the Treatment of Non-infectious Intermediate Uveitis

NCT02125266Phase 1Terminated

Safety and Preliminary Efficacy Study of V404 PDS in Uveitis

NCT00344253Phase 3CompletedPrimary

Randomized, Controlled Trial to Test the Efficacy of Interferon Beta in the Treatment of Intermediate Uveitis

NCT00404612Phase 3Completed

A Study of LX211 in Active Sight Threatening, Non-infectious Intermediate-, Anterior and Intermediate-, Posterior-, or Pan-Uveitis

NCT00404742Phase 3Completed

A Study of LX211 in Clinically Quiescent Non-infectious Intermediate, Anterior and Intermediate, Posterior or Pan-Uveitis

Showing all 18 trials

Research Network

Activity Timeline